Pharmacogenetics and adverse drug reactions

This publication has 27 references indexed in Scilit:

• The pharmacogenetics of β2-adrenergic receptors: Relevance to asthma
  Journal of Allergy and Clinical Immunology, 2000
• METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-Methyltransferase
  Annual Review of Pharmacology and Toxicology, 1999
• Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
  The Lancet, 1999
• Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug research
  Pharmacogenetics, 1998
• Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response
  Schizophrenia Research, 1998
• Pharmacogenetics of antidepressants: clinical aspects
  Acta Psychiatrica Scandinavica, 1997
• MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
  Annual Review of Pharmacology and Toxicology, 1997
• The pharmacogenetics of codeine hypoalgesia
  Pharmacogenetics, 1995
• Genotype or phenotype: the definition of a pharmacogenetic polymorphism
  Pharmacogenetics, 1991
• Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
  Nature, 1988